Christopher W. Krueger, Chief Business Officer at Ventyx Biosciences, Inc. (VTYX), sold 27,383 shares at $39.87 ($1.1M) on 2023-07-03, disclosed to the SEC on 2023-07-05.
Open-market sale of $1.1M VTYX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.57 | 403 | $14K | 1.3% |
| 2 | $34.72 | 214 | $7K | 0.7% |
| 3 | $35.50 | 40 | $1K | 0.1% |
| 4 | $38.05 | 1,960 | $75K | 6.9% |
| 5 | $38.79 | 2,150 | $83K | 7.7% |
| 6 | $38.79 | 2,150 |
| $83K |
| 7.7% |
| 7 | $39.87 | 10,233 | $408K | 37.8% |
| 8 | $39.87 | 10,233 | $408K | 37.8% |
| Total | $39.43 avg | 27,383 | $1.1M | 100% |
| Filing → |
| VTYX | SELL | 2023-10-04 | $869K | — | Filing → |
| VTYX | SELL | 2023-09-07 | $977K | — | Filing → |
| VTYX | SELL | 2023-08-04 | $1.1M | — | Filing → |